Quantum-Si Appoints Rothberg CEO, Hawkins Departs
Ticker: QSIAW · Form: 8-K · Filed: Mar 11, 2024 · CIK: 1816431
| Field | Detail |
|---|---|
| Company | Quantum-Si Inc (QSIAW) |
| Form Type | 8-K |
| Filed Date | Mar 11, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $11.50, $6.00, $8.00, $10.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, executive-appointment, director-departure
Related Tickers: QSI
TL;DR
Rothberg is back as CEO of QSI, Hawkins out. Big changes at the top.
AI Summary
Quantum-Si Incorporated announced on March 8, 2024, changes in its executive and director roles. The company appointed Dr. Jonathan Rothberg as Chief Executive Officer and Chairman of the Board, effective March 8, 2024. Additionally, the company announced the departure of its previous CEO, Jeff Hawkins, and a director, Dr. Christian M. M. Stark, also effective March 8, 2024.
Why It Matters
This leadership change, with the founder Dr. Rothberg taking the CEO role, signals a potential strategic shift and renewed focus for Quantum-Si.
Risk Assessment
Risk Level: medium — Leadership changes can introduce uncertainty and impact strategic execution, warranting a medium risk assessment.
Key Players & Entities
- Quantum-Si Incorporated (company) — Registrant
- Dr. Jonathan Rothberg (person) — Appointed CEO and Chairman of the Board
- Jeff Hawkins (person) — Departing CEO
- Dr. Christian M. M. Stark (person) — Departing Director
- March 8, 2024 (date) — Effective date of appointments and departures
FAQ
Who has been appointed as the new CEO and Chairman of the Board of Quantum-Si Incorporated?
Dr. Jonathan Rothberg has been appointed as the new Chief Executive Officer and Chairman of the Board, effective March 8, 2024.
When were the leadership changes effective?
The leadership changes, including the appointment of Dr. Jonathan Rothberg and the departures of Jeff Hawkins and Dr. Christian M. M. Stark, were effective as of March 8, 2024.
Who is the former CEO of Quantum-Si Incorporated that has departed?
Jeff Hawkins is the former CEO of Quantum-Si Incorporated who has departed.
Has there been a change in the Board of Directors?
Yes, Dr. Christian M. M. Stark has departed as a director, and Dr. Jonathan Rothberg has been appointed as Chairman of the Board.
What is the filing date of this 8-K report?
This 8-K report was filed on March 11, 2024.
Filing Stats: 950 words · 4 min read · ~3 pages · Grade level 11.4 · Accepted 2024-03-11 16:49:36
Key Financial Figures
- $0.0001 — stered Class A common stock, par value $0.0001 per share QSI The Nasdaq Stock Mark
- $11.50 — mon stock, each at an exercise price of $11.50 per share QSIAW The Nasdaq Stock Ma
- $6.00 — of the Class A common stock is at least $6.00 (as adjusted) for 20 out of 30 consecut
- $8.00 — of the Class A common stock is at least $8.00 (as adjusted) for 20 out of 30 consecut
- $10.00 — of the Class A common stock is at least $10.00 (as adjusted) for 20 out of 30 consecut
- $12.00 — of the Class A common stock is at least $12.00 (as adjusted) for 20 out of 30 consecut
Filing Documents
- ef20023893_8k.htm (8-K) — 30KB
- 0001140361-24-012640.txt ( ) — 203KB
- qsi-20240308.xsd (EX-101.SCH) — 4KB
- qsi-20240308_def.xml (EX-101.DEF) — 18KB
- qsi-20240308_lab.xml (EX-101.LAB) — 27KB
- qsi-20240308_pre.xml (EX-101.PRE) — 20KB
- ef20023893_8k_htm.xml (XML) — 6KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 10, 2024, the Board of Directors (the "Board") of Quantum-Si Incorporated (the "Company") approved amendments to two stock option awards previously granted to Jeffrey Hawkins, the Company's President and Chief Executive Officer, to better align the performance-based vesting terms of these awards with the price of the Company's Class A Common Stock, $0.0001 par value per share (the "Class A common stock"). The amended awards, previously granted as of November 9, 2022, were each stock options to purchase 1,390,000 shares of Class A common stock (the "1.5X Option" and "3.5X Option," respectively). The Board approved amendments to the 1.5X Option and the 3.5X Option as follows, effective as of March 15, 2024 (the "Effective Date"): (A) the 1.5X Option shall be amended such that (i) 695,000 shares shall vest if within 3 years of the Effective Date the closing price of the Class A common stock is at least $6.00 (as adjusted) for 20 out of 30 consecutive trading days and (ii) 695,000 shares shall vest if within 3 years of the Effective Date the closing price of the Class A common stock is at least $8.00 (as adjusted) for 20 out of 30 consecutive trading days, and (B) the 3.5X Option shall be amended such that (i) 695,000 shares shall vest if within 3 years of the Effective Date the closing price of the Class A common stock is at least $10.00 (as adjusted) for 20 out of 30 consecutive trading days and (ii) 695,000 shares shall vest if within 3 years of the Effective Date the closing price of the Class A common stock is at least $12.00 (as adjusted) for 20 out of 30 consecutive trading days. In addition, on March 8, 2024, the Compensation Committee of the Board (the "Compensation Committee") approved amendments to two stock option awards previously granted to Jeffry Keyes, the Company's Chief Financial Offi
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. QUANTUM-SI INCORPORATED By: /s/ Christian LaPointe, Ph.D. Name: Christian LaPointe, Ph.D. Title: General Counsel Date: March 11, 2024